Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: | Completed |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease, Diabetes, Diabetes |
Therapuetic Areas: | Endocrinology, Nephrology / Urology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/31/2019 |
Start Date: | September 20, 2016 |
End Date: | May 15, 2018 |
This trial is conducted globally. The aim of this trial is to investigate efficacy and safety
of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal
impairment.
of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal
impairment.
Inclusion Criteria: - Informed consent obtained before any trial-related activities.
Trial-related activities are any procedures that are carried out as part of the trial,
including activities to determine suitability for the trial - Male or female, age above or
equal to 18 years at the time of signing informed consent - Diagnosed with type 2 diabetes
mellitus for at least 90 days prior to day of screening - HbA1c (glycosylated haemoglobin)
of 7.0-9.5% (53-80 mmol/mol) (both inclusive) - Moderate renal impairment defined as
estimated glomerular filtration rate of 30-59 mL/min/1.73 m^2 as per Chronic Kidney Disease
Epidemiology Collaboration formula - Stable daily dose(s) within 90 days prior to the day
of screening of any of the following treatment regimens:- 1-2 of the following oral
anti-diabetic drugs: - Metformin equal or above 1500 mg or maximum tolerated dose
documented in the subject medical record), - Sulfonylurea (equal or above half of the
maximum approved dose according to local label or maximum tolerated dose as documented in
subject medical record) - Basal insulin alone (20% change in total daily dose of insulin
glargine, insulin detemir, insulin degludec or NPH insulin) or - Metformin (equal or above
1500 mg or maximum tolerated dose documented in the subject medical record) in combination
with basal insulin (20% change in total daily dose of insulin glargine, insulin detemir,
insulin degludec or NPH insulin) Exclusion Criteria: - Female who is pregnant,
breast-feeding or intends to become pregnant or is of child-bearing potential and not using
an adequate contraceptive method (adequate contraceptive measure as required by local
regulation or practice).For certain specific countries: Additional specific requirements
apply - Any disorder, which in the investigator's opinion might jeopardise subject's safety
or compliance with the protocol - Family or personal history of Multiple Endocrine
Neoplasia Type 2 or Medullary Thyroid Carcinoma - History of pancreatitis (acute or
chronic) - History of major surgical procedures involving the stomach potentially affecting
absorption of trial product (e.g. subtotal and total gastrectomy, sleeve gastrectomy,
gastric bypass surgery) - Any of the following: myocardial infarction, stroke or
hospitalisation for unstable angina or transient ischaemic attack within the past 180 days
prior to the day of screening and randomisation - Subjects presently classified as being in
New York Heart Association Class IV - Planned coronary, carotid or peripheral artery
revascularisation known on the day of screening - Subjects with alanine aminotransferase
above 2.5 x upper normal limit - Rapidly progressing renal disease (e.g. such as acute
glomerulonephritis) as judged by the investigator or known nephrotic albuminuria (above
2200 mg/24 hours or above 2200 mg/g) - Use of systemic immunosuppressive treatment within
90 days prior to screening - Treatment with any medication for the indication of diabetes
or obesity other than stated in the inclusion criteria in a period of 90 days before the
day of screening. An exception is short-term insulin treatment for acute illness for a
total of below or equal to 14 days - Known hypoglycaemic unawareness and/or recurrent
severe hypoglycaemic episodes as judged by the investigator - Proliferative retinopathy or
maculopathy requiring acute treatment. Verified by fundus photography or dilated fundoscopy
performed within 90 days prior to randomisation - History or presence of malignant
neoplasms within the last 5 years (except basal and squamous cell skin cancer and carcinoma
in situ)
We found this trial at
56
sites
Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials
